iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares BLISSGVS BLISS GVS PHARMA LIMITED INE416D01022 Board Meeting New 2025-11-06 Yes 2025-10-01 2025-11-08 Financial results Unaudited Standalone And Consolidated Half Yearly September 2025 Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Thursday, November 06, 2025 at the registered office of the Company to consider and approve, inter alia, the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2025.